Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

被引:86
|
作者
Eikenboom, JCJ [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Haematol, Haemostasis & Thrombosis Res Ctr, NL-2300 RC Leiden, Netherlands
关键词
von Willebrand disease; von Willebrand factor; drug therapy; antibodies; factor VIII; congenital; genetics; mutation;
D O I
10.1053/beha.2001.0139
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand disease type 3 is the most severe form of this condition. Patients present with a moderate-to-severe bleeding tendency. The plasma von Willebrand factor level in these patients is very low or undetectable. Although rare, von Willebrand disease type 3 is of major interest because of its severe clinical presentation, the need for replacement therapy and the risk of occurrence of alloantibodies after the infusion of plasma concentrates. The inheritance of type 3 disease is typically autosomal recessive. The parents are often consanguineous, although compound heterozygous inheritance does occur. The molecular basis of von Willebrand disease type 3 has recently been studied in detail, several molecular defects being identified. This chapter will focus on the clinical and molecular aspects of type 3 von Willebrand disease.
引用
收藏
页码:365 / 379
页数:15
相关论文
共 50 条
  • [41] Bleeding manifestations in males with von Willebrand disease
    Ziv, O
    Ragni, MV
    HAEMOPHILIA, 2004, 10 (02) : 162 - 168
  • [42] First report of inhibitory von Willebrand factor alloantibodies in type 2B von Willebrand disease
    Baaij, Marije
    van Galen, Karin P. M.
    Urbanus, Rolf T.
    Nigten, Jeannet
    Eikenboom, Jeroen H. C.
    Schutgens, Roger E. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (03) : 424 - 427
  • [43] Molecular and cellular biology of von Willebrand factor
    Denis, CV
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (01) : 3 - 8
  • [44] Molecular and Cellular Biology of von Willebrand Factor
    Cécile V. Denis
    International Journal of Hematology, 2002, 75 : 3 - 8
  • [45] MOLECULAR AND GENETIC VERIFICATION OF VON WILLEBRAND DISEASE TYPE 2N
    Chernetskaya, D. M.
    Surin, V. L.
    Salomashkina, V. V.
    Pshenichnikova, O. S.
    Yakovleva, E., V
    Zozulya, N., I
    Sudarikov, A. B.
    Likhacheva, E. A.
    Shabanova, E. S.
    Perina, F. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (02): : 172 - 180
  • [46] Update on Molecular Testing in von Willebrand Disease
    Batlle, Javier
    Perez-Rodriguez, Almudena
    Corrales, Irene
    Borras, Nina
    Costa Pinto, Joana
    Fernanda Lopez-Fernandez, Maria
    Vidal, Francisco
    Cid, Ana Rosa
    Bonanad, Santiago
    Parra, Rafael
    Eva Mingot-Castellano, Maria
    Navarro, Nira
    Altisent, Carmen
    Perez-Montes, Rocio
    Marcellini, Shally
    Moreto, Ana
    Herrero, Sonia
    Soto, Inmaculada
    Bernardo-Gutierrez, Angel
    Fernandez Mosteirin, Nuria
    Jimenez-Yuste, Victor
    Alonso, Nieves
    Jacob, Aurora de Andres
    Fontanes, Emilia
    Campos, Rosa
    Jose Paloma, Maria
    Bermejo, Nuria
    Berrueco, Ruben
    Mateo, Jose
    Arribalzaga, Karmele
    Marco, Pascual
    Palomo, Angeles
    Castro Quismondo, Nerea
    Inigo, Belen
    del Mar Nieto, Maria
    Vidal, Rosa
    Paz Martinez, Maria
    Aguinaco, Reyes
    Tenorio, Maria
    Ferreiro, Maria
    Garcia-Frade, Javier
    Maria Rodriguez-Huerta, Ana
    Cuesta, Jorge
    Rodriguez-Gonzalez, Ramon
    Garcia-Candel, Faustino
    Dobon, Manuela
    Aguilar, Carlos
    Maria Bastida, Jose
    Nunez, Ramiro
    Azanzazu Aguirre, Maria
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (07) : 708 - 719
  • [47] Gastrointestinal angiodysplasia in two patients with type 3 von Willebrand disease
    Liao, Li-Chin
    Liao, Szu-Chia
    Chang, Chung-Hsin
    Shih, Ming-Yang
    Wang, Jiaan-Der
    BLOOD COAGULATION & FIBRINOLYSIS, 2019, 30 (05) : 243 - 245
  • [48] An evaluation of von Willebrand factor (recombinant) therapy for adult patients living with severe type 3 von Willebrand disease
    Hancock, John M.
    Escobar, Miguel A.
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (03) : 157 - 161
  • [49] A molecular approach to the classification of von Willebrand disease
    Schneppenheim, R
    Budde, U
    Ruggeri, ZM
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (02) : 281 - 298
  • [50] Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3
    Berntorp, Erik
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (06) : 621 - 625